AbbVie Inc.
BG ˙ BUL ˙ US00287Y1091
SecurityBG:4AB / AbbVie Inc.
InstitutionDelphi Management Inc /ma/
Latest Disclosed Ownership5,302 shares
Latest Disclosed Value $ 1,153
Delphi Management Inc /ma/ reports 21.10% decrease in ownership of 4AB / AbbVie Inc.

On April 20, 2026 - Delphi Management Inc /ma/ filed a 13F-HR form disclosing ownership of 5,302 shares of AbbVie Inc. (BG:4AB) valued at $1,153 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 21, 2026 disclosing 6,720 shares of AbbVie Inc.. This represents a change in shares of -21.10% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-20 2026-03-31 13F ABBVIE COM 00287Y109 5,302 -1,418 -21.10 1 0.00 1.3797
2026-01-21 2025-12-31 13F ABBVIE COM 00287Y109 6,720 -210 -3.03 2 0.00 1.4948
2025-10-15 2025-09-30 13F ABBVIE COM 00287Y109 6,930 1,323 23.60 2 0.00 1.4889
2025-07-07 2025-06-30 13F ABBVIE COM 00287Y109 5,607 -398 -6.63 1 0.00 1.0058
2025-04-08 2025-03-31 13F ABBVIE COM 00287Y109 6,005 -615 -9.29 1 0.00 1.2819
2025-02-10 2024-12-31 13F ABBVIE COM 00287Y109 6,620 -73 -1.09 1 0.00 1.1365
2025-02-10 2024-09-30 13F ABBVIE COM 00287Y109 6,693 -1,225 -15.47 1 0.00 1.2008
2024-08-26 2024-06-30 13F AbbVie COM 00287Y109 7,918 12 0.15 1 0.00 1.1072
2024-05-21 2024-03-31 13F ABBVIE COM 00287Y109 7,906 -1,351 -14.59 1 0.00 1.1170
2024-05-20 2023-12-31 13F ABBVIE COM 00287Y109 9,257 1,316 16.57 1 0.00 1.0331
2024-01-25 2023-09-30 13F ABBVIE COM 00287Y109 7,941 16 0.20 1 0.00 1.2132
2023-08-28 2023-06-30 13F ABBVIE COM 00287Y109 7,925 -234 -2.87 1 0.00 1.1102
2023-07-11 2022-12-31 13F ABBVIE COM 00287Y109 8,159 -3,895 -32.31 1 -99.94 1.5956
2022-02-15 2021-12-31 13F ABBVIE COM 00287Y109 12,054 396 3.40 1,632 29.73 1.5363
2021-11-15 2021-09-30 13F ABBVIE COM 00287Y109 11,658 126 1.09 1,258 -3.16 1.2943
2021-08-16 2021-06-30 13F ABBVIE COM 00287Y109 11,532 236 2.09 1,299 6.30 1.2394
2021-05-14 2021-03-31 13F ABBVIE COM 00287Y109 11,296 -2,157 -16.03 1,222 19.92 1.2971
2019-10-07 2019-09-30 13F ABBVIE COM 00287Y109 13,453 -408 -2.94 1,019 1.09 0.9882
2019-08-20 2019-06-30 13F ABBVIE COM 00287Y109 13,861 -20 -0.14 1,008 -9.92 0.9055
2019-05-13 2019-03-31 13F ABBVIE COM 00287Y109 13,881 -4,524 -24.58 1,119 -34.06 1.0365
2019-02-22 2018-12-31 13F ABBVIE COM 00287Y109 18,405 476 2.65 1,697 0.06 1.5368
2018-11-13 2018-09-30 13F ABBVIE COM 00287Y109 17,929 -592 -3.20 1,696 -0.70 1.0892
2018-08-20 2018-06-30 13F ABBVIE COM 00287Y109 18,521 -3,726 -16.75 1,708 -18.90 1.0533
2018-05-14 2018-03-31 13F ABBVIE COM 00287Y109 22,247 -5,498 -19.82 2,106 -21.51 1.2810
2018-02-01 2017-12-31 13F ABBVIE COM 00287Y109 27,745 -5,204 -15.79 2,683 -8.37 1.5283
2017-11-20 2017-09-30 13F ABBVIE COM 00287Y109 32,949 -104 -0.31 2,928 22.15 1.6368
2017-08-15 2017-06-30 13F ABBVIE COM 00287Y109 33,053 -7,814 -19.12 2,397 -9.99 1.3287
2017-05-15 2017-03-31 13F ABBVIE COM 00287Y109 40,867 3,051 8.07 2,663 12.46 1.5193
2017-02-16 2016-12-31 13F ABBVIE COM 00287Y109 37,816 1,068 2.91 2,368 2.16 1.3828
2016-11-17 2016-09-30 13F ABBVIE COM 00287Y109 36,748 -3,390 -8.45 2,318 -6.72 1.4430
2016-08-15 2016-06-30 13F ABBVIE COM 00287Y109 40,138 -1,821 -4.34 2,485 3.67 1.5932
2016-05-13 2016-03-31 13F ABBVIE COM 00287Y109 41,959 1,161 2.85 2,397 -0.83 1.4414
2016-02-16 2015-12-31 13F/A-1 ABBVIE COM 00287Y109 40,798 -114,057 -73.65 2,417 -71.31 1.5571
2016-02-16 2015-12-31 13F ABBVIE COM 00287Y109 40,798 2,417
2015-11-13 2015-09-30 13F ABBVIE COM 00287Y109 154,855 2,945 1.94 8,426 -17.45 1.3219
2015-08-07 2015-06-30 13F ABBVIE COM 00287Y109 151,910 32,425 27.14 10,207 45.92 1.3732
2015-05-20 2015-03-31 13F ABBVIE COM 00287Y109 119,485 119,485 6,995 0.9287
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.